Skip to content

Effects of a 4-week Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) Program on Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD)

Effects of a 4-week Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) Program on Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00971490
Enrollment
30
Registered
2009-09-03
Start date
2007-08-31
Completion date
2008-12-31
Last updated
2009-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

COPD, FEV1, beta endorphin, SGRQ, Acu-TENS

Brief summary

The objectives of this study are to investigate the effectiveness of Acu-TENS (transcutaneous electrical nerve stimulation applied on acupoints) on lung functions and quality of life and to explore the associated underlying mechanisms in subjects with COPD.

Interventions

DEVICEAcu-TENS (Transcutaneous electrical nerve stimulation)

Transcutaneous electrical nerve stimulation applied onto acupuncture point

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis with COPD

Exclusion criteria

* allergic to gel * unable to perform spirometry * unable to communicate * no history of infection or exacerbation of respiratory symptoms

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in one second (FEV1), forced vital capacity (FVC)measured before and after the 4-week program

Secondary

MeasureTime frame
beta endorphin, St George Respiratory Questionnaire (SGRQ)measured before and after the 4-week program

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026